288 related articles for article (PubMed ID: 35799022)
1. Research Progress in the Relationship Between P2X7R and Cervical Cancer.
Tang Y; Qiao C; Li Q; Zhu X; Zhao R; Peng X
Reprod Sci; 2023 Mar; 30(3):823-834. PubMed ID: 35799022
[TBL] [Abstract][Full Text] [Related]
2. The P2X7 purinergic receptor: a potential therapeutic target for lung cancer.
Li Q; Zhu X; Song W; Peng X; Zhao R
J Cancer Res Clin Oncol; 2020 Nov; 146(11):2731-2741. PubMed ID: 32892231
[TBL] [Abstract][Full Text] [Related]
3. Effect of P2X7 receptor on tumorigenesis and its pharmacological properties.
Zhang WJ; Hu CG; Zhu ZM; Luo HL
Biomed Pharmacother; 2020 May; 125():109844. PubMed ID: 32004973
[TBL] [Abstract][Full Text] [Related]
4. P2X7 receptor involved in antitumor activity of atractylenolide I in human cervical cancer cells.
Han Y; Bai C; He XM; Ren QL
Purinergic Signal; 2023 Mar; 19(1):145-153. PubMed ID: 35235139
[TBL] [Abstract][Full Text] [Related]
5. Purinergic P2X7 receptor as a potential therapeutic target in depression.
Qi W; Jin X; Guan W
Biochem Pharmacol; 2024 Jan; 219():115959. PubMed ID: 38052270
[TBL] [Abstract][Full Text] [Related]
6. Progress in the relationship between P2X7R and colorectal cancer.
Bai X; Li X; Qiao C; Tang Y; Zhao R; Peng X
Mol Biol Rep; 2023 Feb; 50(2):1687-1699. PubMed ID: 36417079
[TBL] [Abstract][Full Text] [Related]
7. Purinergic P2X7 Receptor: A Cation Channel Sensitive to Tumor Microenvironment.
Scarpellino G; Genova T; Munaron L
Recent Pat Anticancer Drug Discov; 2019; 14(1):32-38. PubMed ID: 30652649
[TBL] [Abstract][Full Text] [Related]
8. Structure, function and techniques of investigation of the P2X7 receptor (P2X7R) in mammalian cells.
Di Virgilio F; Jiang LH; Roger S; Falzoni S; Sarti AC; Vultaggio-Poma V; Chiozzi P; Adinolfi E
Methods Enzymol; 2019; 629():115-150. PubMed ID: 31727237
[TBL] [Abstract][Full Text] [Related]
9. Antagonism of the ATP-gated P2X7 receptor: a potential therapeutic strategy for cancer.
Drill M; Jones NC; Hunn M; O'Brien TJ; Monif M
Purinergic Signal; 2021 Jun; 17(2):215-227. PubMed ID: 33728582
[TBL] [Abstract][Full Text] [Related]
10. Recent Advances in the Development of Antidepressants Targeting the Purinergic P2X7 Receptor.
Lee S; Ha H; Jang J; Byun Y
Curr Med Chem; 2023; 30(2):164-177. PubMed ID: 35770396
[TBL] [Abstract][Full Text] [Related]
11. Effect of the purinergic receptor P2X7 on Chlamydia infection in cervical epithelial cells and vaginally infected mice.
Darville T; Welter-Stahl L; Cruz C; Sater AA; Andrews CW; Ojcius DM
J Immunol; 2007 Sep; 179(6):3707-14. PubMed ID: 17785807
[TBL] [Abstract][Full Text] [Related]
12. The P2X7 receptor regulates cell survival, migration and invasion of pancreatic ductal adenocarcinoma cells.
Giannuzzo A; Pedersen SF; Novak I
Mol Cancer; 2015 Nov; 14():203. PubMed ID: 26607222
[TBL] [Abstract][Full Text] [Related]
13. P2X7 receptor deletion suppresses γ-radiation-induced hyposalivation.
Gilman KE; Camden JM; Klein RR; Zhang Q; Weisman GA; Limesand KH
Am J Physiol Regul Integr Comp Physiol; 2019 May; 316(5):R687-R696. PubMed ID: 30892913
[TBL] [Abstract][Full Text] [Related]
14. P2X7 Purinergic Receptor Is Involved in the Pathophysiology of Mania: a Preclinical Study.
Gubert C; Andrejew R; Leite CE; Moritz CEJ; Scholl J; Figueiro F; Kapczinski F; da Silva Magalhães PV; Battastini AMO
Mol Neurobiol; 2020 Mar; 57(3):1347-1360. PubMed ID: 31729632
[TBL] [Abstract][Full Text] [Related]
15. Anthraquinone emodin inhibits human cancer cell invasiveness by antagonizing P2X7 receptors.
Jelassi B; Anchelin M; Chamouton J; Cayuela ML; Clarysse L; Li J; Goré J; Jiang LH; Roger S
Carcinogenesis; 2013 Jul; 34(7):1487-96. PubMed ID: 23524196
[TBL] [Abstract][Full Text] [Related]
16. P2X7 receptor antagonists: a patent review (2010-2015).
Park JH; Kim YC
Expert Opin Ther Pat; 2017 Mar; 27(3):257-267. PubMed ID: 27724045
[TBL] [Abstract][Full Text] [Related]
17. Discovery of bilirubin as novel P2X7R antagonist with anti-tumor activity.
Zhao Y; Chen X; He C; Gao G; Chen Z; Du J
Bioorg Med Chem Lett; 2021 Nov; 51():128361. PubMed ID: 34543755
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel P2X7R antagonists by using structure-based virtual screening and cell-based assays.
Zhao Y; Chen X; Lyu S; Ding Z; Wu Y; Gao Y; Du J
Chem Biol Drug Des; 2021 Jul; 98(1):192-205. PubMed ID: 33993620
[TBL] [Abstract][Full Text] [Related]
19. Purinergic receptors: new targets for the treatment of gout and fibrosis.
Gicquel T; Le Daré B; Boichot E; Lagente V
Fundam Clin Pharmacol; 2017 Apr; 31(2):136-146. PubMed ID: 27885718
[TBL] [Abstract][Full Text] [Related]
20. Roles of purinergic P2X
McLarnon JG
Cancer Lett; 2017 Aug; 402():93-99. PubMed ID: 28536012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
